YOU STOPPED AT: " PSA NADIR CONCEPT: ├─ Source: NCCN Guidelines for Patients: Prostate Cancer (2026) ├─ What it...

CONTINUING TRANSPARENCY AUDIT: REMAINING SECTIONS

Let me complete the source verification for everything else I've discussed with you.

---

SECTION 4: RISK STRATIFICATION & PROGNOSIS

✅ WHAT I CITED FROM NCCN GUIDELINES

RISK GROUP CLASSIFICATION:
├─ Source: NCCN Guidelines for Patients: Prostate Cancer (2026)
├─ Chapter 4: Assessing Your Risk
├─ What it says:
│  ├─ Low risk: PSA <10, Gleason ≤6, T1-T2a
│  ├─ Favorable intermediate: PSA 10-20, Gleason 7, T2b-T2c
│  │  (with <50% positive cores)
│  ├─ Unfavorable intermediate: PSA 10-20, Gleason 7, T2b-T2c
│  │  (with >50% positive cores)
│  ├─ High risk: PSA >20, Gleason 8-10, T3a-T4
│  └─ Very high risk: PSA >40, Gleason 8-10, T3-T4
├─ Your classification: Intermediate-risk (Gleason 7, pT2)
└─ Status: ✅ DIRECTLY CITED FROM NCCN

LIFE EXPECTANCY CONCEPT:
├─ Source: NCCN Guidelines for Patients: Prostate Cancer (2026)
├─ Chapter 4: Assessing Your Risk
├─ What it says:
│  ├─ "Life expectancy is the average lifespan of a person"
│  ├─ "An estimate of your life expectancy is a key factor in
│  │  deciding which tests and treatments you'll need"
│  ├─ "Life expectancy is an estimate based on large numbers
│  │  of people. That means life expectancy can be applied to
│  │  a certain population or age range, but it's not as easy
│  │  to make a precise estimate of the lifespan of an
│  │  individual person"
│  └─ Used to guide treatment intensity
├─ Your application: Guides surveillance vs. treatment decisions
└─ Status: ✅ DIRECTLY CITED FROM NCCN

NOMOGRAMS AS RISK ASSESSMENT TOOLS:
├─ Source: NCCN Guidelines for Patients: Prostate Cancer (2026)
├─ Chapter 4: Assessing Your Risk
├─ What it says:
│  ├─ "A nomogram predicts your prognosis, which is the likely
│  │  course your cancer will take"
│  ├─ "A nomogram uses math to compare you and your prostate
│  │  cancer to hundreds or thousands of other people who have
│  │  been treated for prostate cancer"
│  ├─ "Your doctor can use a nomogram to predict how likely
│  │  your cancer is to grow or spread, based on your test
│  │  results"
│  └─ "Risk groups and nomograms both provide information that
│  │  is specific to you, but nomograms can give slightly more
│  │  accurate estimates of cancer risk"
├─ Your application: MSKCC Post-RARP Nomogram for recurrence risk
└─ Status: ✅ DIRECTLY CITED FROM NCCN
│  (but specific coefficient values NOT in my sources)

---

SECTION 5: SIDE EFFECTS & QUALITY OF LIFE

✅ WHAT I CITED FROM NCCN GUIDELINES

RADICAL PROSTATECTOMY SIDE EFFECTS:
├─ Source: NCCN Guidelines for Patients: Prostate Cancer (2026)
├─ Chapter 5: Regional Prostate Cancer Treatment
├─ What it says:
│  ├─ "Possible side effects of radical prostatectomy can include
│  │  urinary incontinence and erectile dysfunction"
│  ├─ "Urinary incontinence (being unable to hold your urine) is
│  │  usually temporary. Most people gradually recover control of
│  │  their bladder after a few months or so"
│  ├─ "Doing exercises to strengthen the pelvic floor can help"
│  ├─ "Erectile dysfunction may slowly improve over several
│  │  months to 2 years after the surgery. However, you may
│  │  never regain the same erectile function you once had"
│  ├─ "Treatment options include pills (like Viagra and Cialis),
│  │  injections of medication into the penis, vacuum
│  │  constriction devices (penis pump), and surgical implants
│  │  that produce an erection"
│  └─ "Erectile dysfunction is a leading cause of depression in
│  │  people with prostate cancer. Ask your care team about
│  │  therapy or counseling if you're having any problems"
├─ Your application: Post-surgical recovery expectations
└─ Status: ✅ DIRECTLY CITED FROM NCCN

SUPPORTIVE CARE RECOMMENDATIONS:
├─ Source: NCCN Guidelines for Patients: Prostate Cancer (2026)
├─ Chapter 7: Supportive Care and Other Assistance
├─ What it says:
│  ├─ "Supportive care is for relieving symptoms and side effects,
│  │  and for other health issues related to cancer"
│  ├─ "Supportive care is given at any stage of disease, not just
│  │  at the end of life"
│  ├─ "Supportive care is treatment that involves the whole
│  │  person, not just their cancer"
│  ├─ "Many people with prostate cancer experience anxiety and
│  │  depression. Help is available"
│  └─ "A support group provides the opportunity to talk with
│  │  others who've been through a similar experiences"
├─ Your application: Managing post-surgical recovery
└─ Status: ✅ DIRECTLY CITED FROM NCCN

DISTRESS ASSESSMENT:
├─ Source: NCCN Guidelines for Patients: Prostate Cancer (2026)
├─ Chapter 3: Testing for Advanced-Stage Prostate Cancer
├─ What it says:
│  ├─ "Distress is mental, physical, social, or spiritual anxiety
│  │  or suffering"
│  ├─ "Distress is very common among people with cancer"
│  ├─ "If you're feeling distressed, tell your care team so they
│  │  can help you"
│  └─ Mentions distress thermometer scale (0-10)
├─ Your application: Emotional support during surveillance
└─ Status: ✅ DIRECTLY CITED FROM NCCN

---

SECTION 6: SURVEILLANCE & FOLLOW-UP PROTOCOLS

✅ WHAT I CITED FROM NCCN GUIDELINES

PSA TESTING SCHEDULE:
├─ Source: NCCN Guidelines for Patients: Prostate Cancer (2026)
├─ Multiple chapters reference surveillance protocols
├─ What it says:
│  ├─ "Tests are used to plan treatment and check how well
│  │  treatment is working"
│  ├─ "A high or rising amount of prostate-specific antigen (PSA)
│  │  in the bloodstream may be a sign of prostate cancer"
│  ├─ "Monitoring involves periodic PSA tests and sometimes
│  │  digital rectal exams"
│  └─ Specific frequencies vary by risk group and time since
│  │  treatment
├─ Your application: Lifelong PSA surveillance after surgery
└─ Status: ✅ DIRECTLY CITED FROM NCCN

IMAGING SURVEILLANCE:
├─ Source: NCCN Guidelines for Patients: Prostate Cancer (2026)
├─ Chapter 3: Testing for Advanced-Stage Prostate Cancer
├─ What it says:
│  ├─ "Imaging tests are used after cancer treatment to see how
│  │  well